Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and ...

Summary by Enid News & Eagle
FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the pricing of an underwritten public offering of 6,875,000 shares…

1 Articles

Enid News & EagleEnid News & Eagle
Lean Left

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and ...

FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the pricing of an underwritten public offering of 6,875,000 shares…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news in on Thursday, January 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Florham Park icon

Florham Park

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal